Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

OBJECTIVE: We assessed trabectedin in patients with advanced uterine leiomyosarcoma (uLMS) in real-life clinical practice given according to the marketing authorization. METHODS: Thirty-six women from 11 tertiary hospitals across Spain who received trabectedin after anthracycline-containing regimen/...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio, María Jesús, Lecumberri, María José, Varela, Silvia, Alarcón, Jesús, Ortega, María Eugenia, Gaba, Lydia, Espinós, Jaime, Calzas, Julia, Barretina, Pilar, Ruiz, Isabel, Marquina, Gloria, Santaballa, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296187/
https://www.ncbi.nlm.nih.gov/pubmed/32566719
http://dx.doi.org/10.1016/j.gore.2020.100594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296187/
https://www.ncbi.nlm.nih.gov/pubmed/32566719
http://dx.doi.org/10.1016/j.gore.2020.100594

Ejemplares similares